Terms: = Germ cell tumor AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
18 results:
1. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.
Liu M; Xu X; Fan S; Ren H; Zhao Y; Guan H
Neurol Sci; 2024 Jan; 45(1):253-260. PubMed ID: 37580515
[TBL] [Abstract] [Full Text] [Related]
3. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Borbon LC; Tran CG; Sherman SK; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2022 Oct; 29(11):6936-6946. PubMed ID: 35802214
[TBL] [Abstract] [Full Text] [Related]
4. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract] [Full Text] [Related]
5. Detection of disease-causing mutations in prostate cancer by NGS sequencing.
Mangolini A; Rocca C; Bassi C; Ippolito C; Negrini M; Dell'Atti L; Lanza G; Gafà R; Bianchi N; Pinton P; Aguiari G
Cell Biol Int; 2022 Jul; 46(7):1047-1061. PubMed ID: 35347810
[TBL] [Abstract] [Full Text] [Related]
6. Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.
Wilson MA; Zhong J; Johannet P; Lee Y; Masub N; Wechter T; Moran U; Berman RS; Shapiro RL; Weber J; Pavlick A; Osman I
Melanoma Res; 2020 Oct; 30(5):492-499. PubMed ID: 32804707
[TBL] [Abstract] [Full Text] [Related]
7. Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
Wohlmuth C; Wohlmuth-Wieser I; May T; Vicus D; Gien LT; Laframboise S
Am J Clin Dermatol; 2020 Apr; 21(2):285-295. PubMed ID: 31784896
[TBL] [Abstract] [Full Text] [Related]
8. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
[TBL] [Abstract] [Full Text] [Related]
9. Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience.
Snyder BM; Mounessa JS; Fazzari M; Caravaglio JV; Kretowicz A; Braunberger T; Wells K; Dunnick CA; Dellavalle RP; Alkousakis T
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447632
[TBL] [Abstract] [Full Text] [Related]
10. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract] [Full Text] [Related]
11. An analysis of clinical characteristics and patient outcomes in primary mediastinal sarcomas.
Abdel-Rahman O
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1071-1076. PubMed ID: 28889760
[TBL] [Abstract] [Full Text] [Related]
12. Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.
Giannatempo P; Pond GR; Sonpavde G; Albany C; Loriot Y; Sweeney CJ; Salvioni R; Colecchia M; Nicolai N; Raggi D; Rice KR; Flack CK; El Mouallem NR; Feldman H; Fizazi K; Einhorn LH; Foster RS; Necchi A; Cary C
J Urol; 2016 Jul; 196(1):95-100. PubMed ID: 26748165
[TBL] [Abstract] [Full Text] [Related]
13. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
[TBL] [Abstract] [Full Text] [Related]
14. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features and post-surgical outcome of patients with astroblastoma.
Sughrue ME; Choi J; Rutkowski MJ; Aranda D; Kane AJ; Barani IJ; Parsa AT
J Clin Neurosci; 2011 Jun; 18(6):750-4. PubMed ID: 21507653
[TBL] [Abstract] [Full Text] [Related]
16. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
[TBL] [Abstract] [Full Text] [Related]
17. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.
Beppu K; Jaboine J; Merchant MS; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2004 Jan; 96(1):46-55. PubMed ID: 14709738
[TBL] [Abstract] [Full Text] [Related]
18. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
[TBL] [Abstract] [Full Text] [Related]
